| Max-Planck-Gesellschaft zur foerderung der Wissenschaften, e. V. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120046458 | METHOD FOR THE PRODUCING ALPHA-1, 6-BRANCHED ALPHA-1, 4-GLUCANS FROM SUCROSE - Nucleic acid molecules which encode a branching enzyme from a bacterium of the genus | 02-23-2012 |
| 20100143386 | FGFR4 Promotes Cancer Cell Resistance in Response to Chemotherapeutic Drugs - The present invention relates to Fibroblast-Growth Factor Receptor 4 (FGRF4) inhibitors for co-administration with a therapeutic procedure or/and agent for the prevention, alleviation or/and treatment of a hyperproliferative disorder, e.g. cancer, such as chemotherapy resistant cancer. Further, the present invention relates to a diagnostic procedure wherein expression status and/or polymorphisms of the FGFR | 06-10-2010 |
| 20100112234 | METHOD FOR THE CREATION OF PLANAR VARIATIONS IN SIZE OR DISTANCE IN NANOSTRUCTURE PATTERNS ON SURFACES - A method for creating extensive variations in size or distance in nanostructure patterns on surfaces preferably includes: a) contacting a substrate with a liquid phase containing organic two-block or multi-block copolymer micelles, which are charged with an inorganic metal compound, by immersion into this liquid phase, during which chemically different polymer domains including inorganic metal compounds enclosed in micelles are deposited on the substrate; b) withdrawing the substrate from the liquid phase at a predetermined withdrawing speed, which is varied continuously or gradually, so that a gradient of the lateral separation length of the polymer domains is produced on the substrate surface; c) converting the deposited inorganic metal compounds by an oxidation- or reduction treatment into inorganic nanoparticles and optionally complete or partial removal of the organic polymer by a plasma treatment, wherein positions and lateral separation length of the nanoparticles obtained are determined by those of deposited polymer domains. | 05-06-2010 |
| 20100009459 | METHOD AND MICROFLUIDIC DEVICE FOR COMBINING REACTION COMPONENTS CONTAINED IN LIQUIDS - The invention relates to a method and a microfluidic device for combining reaction components contained in liquids. The method comprises the steps: application of at least one first liquid filament containing a first reaction component on a first carrier substrate; application of at least one second liquid filament containing a second reaction component on a second carrier substrate; positioning of the two carrier substrates relative to each other at a predetermined distance such that the liquid filaments face each other; and bringing at least one of the at least one first liquid filament into contact with at least one of the at least one second liquid filament by creating at least one connecting point of the respective first and second liquid filaments. A microfluidic device for combining reaction components contained in liquids comprises two carrier substrates each being adapted for accommodating at least one first and at least one second liquid filament, wherein the liquid filaments are preferably each accommodated in a receiving means which is comprised in the carrier substrate. | 01-14-2010 |
| 20100008021 | Porous Carbon Electrode With Conductive Polymer Coating - An extremely high-performance polyaniline electrode was prepared by potentiostatic deposition of aniline on hierarchically porous carbon monolith (HPCM), which was carbonized from mesophase pitch. A capacitance value of 2200 F g | 01-14-2010 |
| 20090274605 | CONTINUOUS SILAZANE CLEAVAGE METHOD - The invention relates to a continuous silazane cleavage method, especially for use in the production of molecular precursors for non-oxidic inorganic ceramics. | 11-05-2009 |
| 20090084162 | CHEMICAL SENSOR - The application relates to a chemical sensor device comprising a substrate ( | 04-02-2009 |
| 20080241144 | Prohibitin as Target for Cancer Therapy - The present invention relates to pharmaceutical compositions comprising inhibitors of Prohibitin (PHB) for the prevention or/and treatment of hyperproliferative disorders. | 10-02-2008 |
